CAS: 811803-05-1 - N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]nicotinamide methanesulfonate (1:1)
Fórmula:C25H27N5O4S
InChI:InChI=1S/C24H23N5O/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30)
Clave InChI:InChIKey=WPEWQEMJFLWMLV-UHFFFAOYSA-N
SMILES:N#CC1(C2=CC=C(C=C2)NC(=O)C3=CC=CN=C3NCC=4C=CN=CC4)CCCC1
- Sinónimos:
- 3-Pyridinecarboxamide, N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-
- Apatinib
- Apatinib (YN968D1)
- Apatinib mesylate
- Aptinib
- N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide
- N-[4-(1-cyanocyclopentyl)phenyl]-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide
- Rivoceranib
- Yn 968D1
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Apatinib REF: 4Z-A-367001CAS: 811803-05-1 | - - - | A consultar | Lun 13 May 24 | |
Apatinib REF: TR-A726150CAS: 811803-05-1 | - - - | 281,00 €~1.825,00 € | Mar 21 May 24 | |
Apatinib-d8 REF: TR-A726153CAS: 811803-05-1 | - - - | 324,00 €~2.136,00 € | Mar 21 May 24 | |
Apatinib REF: 3D-BA175030CAS: 811803-05-1 | Min. 95% | 93,00 €~463,00 € | Mar 21 May 24 |
Ref: 4Z-A-367001
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Apatinib
Producto controladoRef: TR-A726150
25mg | 281,00 € | |
100mg | 1.176,00 € | |
250mg | 1.825,00 € |
Apatinib-d8
Producto controladoRef: TR-A726153
5mg | 324,00 € | |
50mg | 2.136,00 € |
Apatinib
Ref: 3D-BA175030
5mg | 93,00 € | |
10mg | 125,00 € | |
25mg | 222,00 € | |
50mg | 329,00 € | |
100mg | 463,00 € |